The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
作者： Hariti Saluja , Christos S. Karapetis , Susanne K. Pedersen , Graeme P. Young , Erin L. Symonds
关键词: Colorectal cancer 、 GiST 、 Cancer 、 Primary tumor 、 Gastrointestinal cancer 、 Oncology 、 Chemotherapy 、 Disease 、 Internal medicine 、 Medicine 、 DNA methylation
摘要: … on gastric cancer patients showed that methylation of ctDNA in … Blood testing for proteins are not routinely used for … that the detection of new mutations with ctDNA, or detection of a …
frontiersin.org
flinders.edu.au
sci-hub.se 参考文章(136)
S. Aloe, R. DAlessandro, A. Spila, P. Ferroni, S. Basili, R. Palmirotta, M. Carlini, F. Graziano, R. Mancini, S. Mariotti, M. Cosimelli, M. Roselli, F. Guadagni, Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer International Journal of Biological Markers. ,vol. 18, pp. 21- 27 ,(2003) , 10.5301/JBM.2008.1151
Wei-Ming Kang, Qing-Bin Meng, Jian-Chun Yu, Zhi-Qiang Ma, Zhi-Tian Li, Factors associated with early recurrence after curative surgery for gastric cancer World Journal of Gastroenterology. ,vol. 21, pp. 5934- 5940 ,(2015) , 10.3748/WJG.V21.I19.5934
I. Balgkouranidou, D. Matthaios, A. Karayiannakis, H. Bolanaki, P. Michailidis, N. Xenidis, K. Amarantidis, L. Chelis, G. Trypsianis, E. Chatzaki, E.S. Lianidou, S. Kakolyris, Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutation Research. ,vol. 778, pp. 46- 51 ,(2015) , 10.1016/J.MRFMMM.2015.05.002
Tsung-Hui Hu, Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese World Journal of Gastroenterology. ,vol. 12, pp. 595- 602 ,(2006) , 10.3748/WJG.V12.I4.595
Aung Naing, Gerald S. Falchook, David S. Hong, Veronica R. Holley, Goran Cabrilo, Jennifer J. Wheler, Sarina A. Piha-Paul, Ralph G. Zinner, Agop Y. Bedikian, Michael J. Overman, Bryan K. Kee, Kevin B. Kim, E. Scott Kopetz, Rajyalakshmi Luthra, Frank Diehl, Funda Meric-Bernstam, Razelle Kurzrock, Filip Janku, Philipp Angenendt, Apostolia M. Tsimberidou, Siqing Fu, Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies Oncotarget. ,vol. 6, pp. 12809- 12821 ,(2015) , 10.18632/ONCOTARGET.3373
Karen-Lise Garm Spindler, Niels Pallisgaard, Ane Lindegaard Appelt, Rikke Fredslund Andersen, Jakob V. Schou, Dorte Nielsen, Per Pfeiffer, Mette Yilmaz, Julia S. Johansen, Estrid V. Hoegdall, Anders Jakobsen, Benny V. Jensen, Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy. European Journal of Cancer. ,vol. 51, pp. 2678- 2685 ,(2015) , 10.1016/J.EJCA.2015.06.118
John Ploen, Karen-Lise G Spindler, Rikke F Andersen, Anders Jakobsen, Niels Pallisgaard, Gemcitabine and capecitabine for heavily pre-treated metastatic colorectal cancer patients--a phase II and translational research study. Anticancer Research. ,vol. 34, pp. 845- 850 ,(2014)
Erin L. Symonds, Graeme P. Young, Blood Tests for Colorectal Cancer Screening in the Standard Risk Population Current Colorectal Cancer Reports. ,vol. 11, pp. 397- 407 ,(2015) , 10.1007/S11888-015-0293-2
K G Spindler, A L Appelt, N Pallisgaard, R F Andersen, A Jakobsen, KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer British Journal of Cancer. ,vol. 109, pp. 3067- 3072 ,(2013) , 10.1038/BJC.2013.633
T Matsubara, H Okada, K Yamamoto, H Kinugasa, K Nouso, T Tanaka, K Miyahara, Y Morimoto, C Dohi, Droplet digital PCR measurement of HER2 in patients with gastric cancer. British Journal of Cancer. ,vol. 112, pp. 1652- 1655 ,(2015) , 10.1038/BJC.2015.129